GLENWOOD, Md., Sept. 3, 2019 /PRNewswire/ -- Monte Nido & Affiliates, the nation's leading provider of eating disorder treatment for over twenty-three years, announces the opening of Monte Nido Roxbury Mills in Glenwood, Maryland, on September 3, 2019

LAVAL, France, Sept. 3, 2019 /PRNewswire/ -- Porsolt SAS, a long established preclinical screening, efficacy, and safety CRO, has completed a significant expansion of its research facility, adding a further 5,500 sq.ft. of experimental space.

DURHAM, N.C., Sept. 3, 2019 /PRNewswire/ -- VeraSci, a leading provider of innovative scientific and biotechnology services, announced today that their proprietary functional capacity assessment, the VRFCAT has officially been

MADISON,  Wis., Sept. 3, 2019 /PRNewswire/ -- Hyundai Hope On Wheels® (HHOW), a 501(c)(3) non-profit organization supported by Hyundai and its U.S. dealers, announces Hyundai Young Inves

TUCSON, Ariz., Sept. 3, 2019 /PRNewswire/ -- If a Medicare patient gets a service performed in a hospital-owned facility, Medicare may pay far more than if the same service was done in a physician-owned clinic,

SCOTTSDALE, Ariz., Sept. 3, 2019 /PRNewswire/ -- Medicx Media Solutions (https://medicxmedia.com), the leading analytics-driven healthcare marketing solutions company, today announced that Scott Magnano joins the company as Chief Financial Officer. Scott will play a critical role in

NEW YORK, Sept. 3, 2019 /PRNewswire/ -- Healthfirst, New York's largest not-for-profit health insurance company with nearly 1.4 million members, launched a brand campaign today with a look and feel that is a significant departure from the past. The new creative approach uses crisp and clever copy against bold color blocks in print an

TUCSON, Ariz., Sept. 3, 2019 /PRNewswire/ -- Increasingly expansive and coercive vaccine mandates are placing the supposed collective good of society above the right of patients or their parents to give or withhold informed consent, writes

TUCSON, Ariz., Sept. 3, 2019 /PRNewswire/ -- The antibiotic era began in the 1940s, and with these "miracle drugs" it appeared that mankind was winning what was perceived to be a  war on microbes. "But we overlooked or underestimated their ability to adapt rapidly under the selection pressure of antibiotics," writes

NEW YORK, Sept. 3, 2019 /PRNewswire/ -- In a new study, researchers at Hospital for Special Surgery (HSS), Washington University School of Medicine in St. Louis, and their colleagues report that a low-intensity regimen of warfarin does not appear to be as effective as conventional dosing of the blood thinn